Fig. 2From: Patient-derived xenografts: a relevant preclinical model for drug developmentNOD-SCID mice at passage F2 were treated with the G-quadruplex EMICORON per os at 15 mg/kg/day for 15 consecutive days, starting when a tumor volume of 300 mm3 was evident in mice. Each curve represent untreated (black) or EMICORON-treated mice (red)Back to article page